<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00096733</url>
  </required_header>
  <id_info>
    <org_study_id>A2ALL</org_study_id>
    <secondary_id>U01DK062498-01</secondary_id>
    <nct_id>NCT00096733</nct_id>
  </id_info>
  <brief_title>Adult-to-Adult Living Donor Liver Transplantation Study</brief_title>
  <acronym>A2ALL-1</acronym>
  <official_title>Adult-to-Adult Living Donor Liver Transplantation Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Arbor Research Collaborative for Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>American Society of Transplant Surgeons</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Health Resources and Services Administration (HRSA)</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Arbor Research Collaborative for Health</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      There are two principal purposes of this study: 1) to determine whether it is more beneficial
      for a liver transplant recipient candidate to pursue a living donor liver transplant (LDLT)
      or wait for a deceased donor liver transplant (DDLT), and 2) to study the impact of liver
      donation on the donor's health and quality of life.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Adult to adult living donor liver transplantation (LDLT) is a relatively new procedure
      increasingly used at major transplantation centers. Relatively small numbers of cases are
      performed at any one center and approaches to the patient and donor are too diverse across
      centers to provide reliable and generalizable information on donor and recipient outcomes
      from individual centers. Therefore, a network of nine leading liver transplantation centers
      and a data coordination center (DCC) has been organized to accrue and follow sufficient
      numbers of patients being considered for and undergoing LDLT to provide generalizable results
      from adequately powered studies. This network has established the Adult to Adult Living Donor
      Liver Transplantation Cohort Study (A2ALL) that will conduct both retrospective and
      prospective studies of LDLT.

      The primary study objective is to analyze the effect of choosing to pursue living liver
      donation. The principal hypothesis is that pursuit of a living liver allograft leads to
      decreased pre-transplant morbidity and mortality and better long term outcomes for patients
      starting from the point at which listed patients have a potential donor evaluated (at least a
      history and physical examination). Emerging data suggest that LDLT provides an inferior graft
      because of reduced parenchymal mass and added technical complexity when compared to a whole
      liver used for DDLT. The magnitude of the disadvantage to the LDLT graft will be assessed by
      comparing results between LDLT and DDLT from the time of transplant. Finally, a careful and
      detailed series of studies of potential and actual living liver donors is included as a
      primary objective because of the tremendous importance of this issue to our understanding of
      the impact of the procedure.

      Secondary objectives will address selected biological and clinical issues in transplantation
      structured around the comparison between DDLT and LDLT.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2004</start_date>
  <completion_date type="Actual">August 2010</completion_date>
  <primary_completion_date type="Actual">August 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Survival of the potential liver transplant recipient</measure>
    <time_frame>Time from living donor evaluation to death</time_frame>
    <description>Time from evaluation of a living liver donor until death of the potential recipient, to test the benefit of living liver donation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Recipient survival from time of transplant (either living or deceased donor)</measure>
    <time_frame>From transplant until death or last follow-up</time_frame>
    <description>Recipient survival from transplant to death. The goal is to compare survival among living donor versus deceased donor recipients.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Donor complications</measure>
    <time_frame>From the time of donation until last follow-up</time_frame>
    <description>Donor complications are recorded, and graded using the Clavien scale.</description>
  </other_outcome>
  <other_outcome>
    <measure>Recipient complications</measure>
    <time_frame>From time of transplantation until last follow-up</time_frame>
    <description>Recipient complications are recorded, and graded using the Clavien scale.</description>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">2470</enrollment>
  <condition>Cirrhosis</condition>
  <condition>Hepatitis C</condition>
  <condition>Hepatocellular Carcinoma</condition>
  <arm_group>
    <arm_group_label>Donors</arm_group_label>
    <description>Living liver donors. This label may also refer to those evaluated for liver donation who did not go on to donate, i.e., potential living liver donors.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Recipients</arm_group_label>
    <description>Liver transplant recipients (either living or deceased donor). This label may also refer to those who were evaluated for liver transplantation, but never received a transplant, i.e., potential recipients.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood, serum, fixed tissue samples, frozen tissue samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Potential recipients and donors for transplantation will be evaluated and invited to
        participate in the study if they are eligible for LDLT using standard criteria for this
        procedure according to the practice of the transplant center.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria - Potential Recipients:

          -  Potential recipient listed for single organ (liver) transplantation

          -  Patient is eligible for LDLT

          -  Age â‰¥ 18 years old at the time of donor history and physical exam

          -  Indication for transplant: non-fulminant liver disease

          -  Potential donor scheduled for evaluation (history and physical examination) within
             four weeks

        Inclusion Criteria - Potential Donors:

          -  Meet donor criteria of the transplant center

          -  Age &gt;= 18 years old at donation

          -  Be evaluated with a history and physical examination at the transplant center

          -  Potential donor's recipient listed for single organ (liver) transplantation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert M Merion, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Michigan - A2ALL Data Coordinating Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Carl L Berg, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Virginia Health System</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jean Emond, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Columbia University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of California Los Angeles</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095-7054</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of California San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143-0538</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Colorado Health System</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80262</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Columbia University</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of North Carolina</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599-7210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Virginia</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908-0708</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Virginia Commonwealth University</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23219</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Berg CL, Abecassis M, Brown RS, Everhart JE, Gillespie BW, Hulbert-Shearon TE, Merion RM. Living donor liver transplantation reduces the risk of death of transplant candidates. Hepatology 2004; 40(4)(Suppl 1): 209A.</citation>
  </results_reference>
  <results_reference>
    <citation>Ghobrial RM, Freise CE, Trotter JF, Tong L, Ojo AO, Fair JH, Fisher RA, Emond JC, Koffron AJ, Pruett TL, Olthoff KM; A2ALL Study Group. Donor morbidity after living donation for liver transplantation. Gastroenterology. 2008 Aug;135(2):468-76. doi: 10.1053/j.gastro.2008.04.018. Epub 2008 Apr 22.</citation>
    <PMID>18505689</PMID>
  </results_reference>
  <results_reference>
    <citation>Berg CL, Gillespie BW, Merion RM, Brown RS Jr, Abecassis MM, Trotter JF, Fisher RA, Freise CE, Ghobrial RM, Shaked A, Fair JH, Everhart JE; A2ALL Study Group. Improvement in survival associated with adult-to-adult living donor liver transplantation. Gastroenterology. 2007 Dec;133(6):1806-13. Epub 2007 Sep 14.</citation>
    <PMID>18054553</PMID>
  </results_reference>
  <results_reference>
    <citation>Freise CE, Gillespie BW, Koffron AJ, Lok AS, Pruett TL, Emond JC, Fair JH, Fisher RA, Olthoff KM, Trotter JF, Ghobrial RM, Everhart JE; A2ALL Study Group. Recipient morbidity after living and deceased donor liver transplantation: findings from the A2ALL Retrospective Cohort Study. Am J Transplant. 2008 Dec;8(12):2569-79. doi: 10.1111/j.1600-6143.2008.02440.x. Epub 2008 Oct 24.</citation>
    <PMID>18976306</PMID>
  </results_reference>
  <results_reference>
    <citation>Abecassis MM, Fisher RA, Olthoff KM, Freise CE, Rodrigo DR, Samstein B, Kam I, Merion RM; A2ALL Study Group. Complications of living donor hepatic lobectomy--a comprehensive report. Am J Transplant. 2012 May;12(5):1208-17. doi: 10.1111/j.1600-6143.2011.03972.x. Epub 2012 Feb 15.</citation>
    <PMID>22335782</PMID>
  </results_reference>
  <results_reference>
    <citation>Berg CL, Merion RM, Shearon TH, Olthoff KM, Brown RS Jr, Baker TB, Everson GT, Hong JC, Terrault N, Hayashi PH, Fisher RA, Everhart JE. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era. Hepatology. 2011 Oct;54(4):1313-21. doi: 10.1002/hep.24494.</citation>
    <PMID>21688284</PMID>
  </results_reference>
  <results_reference>
    <citation>Campsen J, Blei AT, Emond JC, Everhart JE, Freise CE, Lok AS, Saab S, Wisniewski KA, Trotter JF; Adult-to-Adult Living Donor Liver Transplantation Cohort Study Group. Outcomes of living donor liver transplantation for acute liver failure: the adult-to-adult living donor liver transplantation cohort study. Liver Transpl. 2008 Sep;14(9):1273-80. doi: 10.1002/lt.21500.</citation>
    <PMID>18756453</PMID>
  </results_reference>
  <results_reference>
    <citation>Everson GT, Terrault NA, Lok AS, Rodrigo del R, Brown RS Jr, Saab S, Shiffman ML, Al-Osaimi AM, Kulik LM, Gillespie BW, Everhart JE; Adult-to-Adult Living Donor Liver Transplantation Cohort Study. A randomized controlled trial of pretransplant antiviral therapy to prevent recurrence of hepatitis C after liver transplantation. Hepatology. 2013 May;57(5):1752-62. doi: 10.1002/hep.25976. Epub 2013 Jan 17.</citation>
    <PMID>22821361</PMID>
  </results_reference>
  <results_reference>
    <citation>Fisher RA, Kulik LM, Freise CE, Lok AS, Shearon TH, Brown RS Jr, Ghobrial RM, Fair JH, Olthoff KM, Kam I, Berg CL; A2ALL Study Group. Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation. Am J Transplant. 2007 Jun;7(6):1601-8.</citation>
    <PMID>17511683</PMID>
  </results_reference>
  <results_reference>
    <citation>Gillespie BW, Merion RM, Ortiz-Rios E, Tong L, Shaked A, Brown RS, Ojo AO, Hayashi PH, Berg CL, Abecassis MM, Ashworth AS, Friese CE, Hong JC, Trotter JF, Everhart JE; A2ALL Study Group. Database comparison of the adult-to-adult living donor liver transplantation cohort study (A2ALL) and the SRTR U.S. Transplant Registry. Am J Transplant. 2010 Jul;10(7):1621-33. doi: 10.1111/j.1600-6143.2010.03039.x. Epub 2010 Feb 25.</citation>
    <PMID>20199501</PMID>
  </results_reference>
  <results_reference>
    <citation>Kulik LM, Fisher RA, Rodrigo DR, Brown RS Jr, Freise CE, Shaked A, Everhart JE, Everson GT, Hong JC, Hayashi PH, Berg CL, Lok AS; A2ALL Study Group. Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: results of the A2ALL cohort. Am J Transplant. 2012 Nov;12(11):2997-3007. doi: 10.1111/j.1600-6143.2012.04272.x. Epub 2012 Sep 20.</citation>
    <PMID>22994906</PMID>
  </results_reference>
  <results_reference>
    <citation>Merion RM, Shearon TH, Berg CL, Everhart JE, Abecassis MM, Shaked A, Fisher RA, Trotter JF, Brown RS Jr, Terrault NA, Hayashi PH, Hong JC; A2ALL Study Group. Hospitalization rates before and after adult-to-adult living donor or deceased donor liver transplantation. Ann Surg. 2010 Mar;251(3):542-9. doi: 10.1097/SLA.0b013e3181ccb370.</citation>
    <PMID>20130466</PMID>
  </results_reference>
  <results_reference>
    <citation>Northup PG, Abecassis MM, Englesbe MJ, Emond JC, Lee VD, Stukenborg GJ, Tong L, Berg CL; Adult-to-Adult Living Donor Liver Transplantation Cohort Study Group. Addition of adult-to-adult living donation to liver transplant programs improves survival but at an increased cost. Liver Transpl. 2009 Feb;15(2):148-62. doi: 10.1002/lt.21671.</citation>
    <PMID>19177435</PMID>
  </results_reference>
  <results_reference>
    <citation>Olthoff KM, Merion RM, Ghobrial RM, Abecassis MM, Fair JH, Fisher RA, Freise CE, Kam I, Pruett TL, Everhart JE, Hulbert-Shearon TE, Gillespie BW, Emond JC; A2ALL Study Group. Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium. Ann Surg. 2005 Sep;242(3):314-23, discussion 323-5.</citation>
    <PMID>16135918</PMID>
  </results_reference>
  <results_reference>
    <citation>Olthoff KM, Abecassis MM, Emond JC, Kam I, Merion RM, Gillespie BW, Tong L; Adult-to-Adult Living Donor Liver Transplantation Cohort Study Group. Outcomes of adult living donor liver transplantation: comparison of the Adult-to-adult Living Donor Liver Transplantation Cohort Study and the national experience. Liver Transpl. 2011 Jul;17(7):789-97. doi: 10.1002/lt.22288.</citation>
    <PMID>21360649</PMID>
  </results_reference>
  <results_reference>
    <citation>Shaked A, Ghobrial RM, Merion RM, Shearon TH, Emond JC, Fair JH, Fisher RA, Kulik LM, Pruett TL, Terrault NA; A2ALL Study Group. Incidence and severity of acute cellular rejection in recipients undergoing adult living donor or deceased donor liver transplantation. Am J Transplant. 2009 Feb;9(2):301-8. doi: 10.1111/j.1600-6143.2008.02487.x. Epub 2008 Dec 15.</citation>
    <PMID>19120082</PMID>
  </results_reference>
  <results_reference>
    <citation>Terrault NA, Shiffman ML, Lok AS, Saab S, Tong L, Brown RS Jr, Everson GT, Reddy KR, Fair JH, Kulik LM, Pruett TL, Seeff LB; A2ALL Study Group. Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation. Liver Transpl. 2007 Jan;13(1):122-9.</citation>
    <PMID>17192908</PMID>
  </results_reference>
  <results_reference>
    <citation>Trotter JF, Hill-Callahan MM, Gillespie BW, Nielsen CA, Saab S, Shrestha R, Talamantes MM, Weinrieb RM; A2ALL Study Group. Severe psychiatric problems in right hepatic lobe donors for living donor liver transplantation. Transplantation. 2007 Jun 15;83(11):1506-8.</citation>
    <PMID>17565325</PMID>
  </results_reference>
  <results_reference>
    <citation>Trotter JF, Wisniewski KA, Terrault NA, Everhart JE, Kinkhabwala M, Weinrieb RM, Fair JH, Fisher RA, Koffron AJ, Saab S, Merion RM; A2ALL Study Group. Outcomes of donor evaluation in adult-to-adult living donor liver transplantation. Hepatology. 2007 Nov;46(5):1476-84.</citation>
    <PMID>17668879</PMID>
  </results_reference>
  <results_reference>
    <citation>Trotter JF, Gillespie BW, Terrault NA, Abecassis MM, Merion RM, Brown RS Jr, Olthoff KM, Hayashi PH, Berg CL, Fisher RA, Everhart JE; Adult-to-Adult Living Donor Liver Transplantation Cohort Study Group. Laboratory test results after living liver donation in the adult-to-adult living donor liver transplantation cohort study. Liver Transpl. 2011 Apr;17(4):409-17. doi: 10.1002/lt.22246.</citation>
    <PMID>21445924</PMID>
  </results_reference>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 12, 2004</study_first_submitted>
  <study_first_submitted_qc>November 12, 2004</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 15, 2004</study_first_posted>
  <last_update_submitted>August 27, 2017</last_update_submitted>
  <last_update_submitted_qc>August 27, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 29, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Living donors</keyword>
  <keyword>Organ procurement</keyword>
  <keyword>Liver transplantation</keyword>
  <keyword>Hepatitis C</keyword>
  <keyword>Hepatocellular carcinoma</keyword>
  <keyword>Hepatectomy</keyword>
  <keyword>Liver regeneration</keyword>
  <keyword>Graft rejection</keyword>
  <keyword>Quality of life</keyword>
  <keyword>Informed consent</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hepatitis</mesh_term>
    <mesh_term>Hepatitis C</mesh_term>
    <mesh_term>Carcinoma, Hepatocellular</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Extracts</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

